Clinical Trial

PET/MRI in Rectal Cancer

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to see which participants have a better treatment response using PET/MRI imaging to study the removed tumor, after they have received a total neoadjuvant therapy (TNT). The treatment choice of long course chemo-radiotherapy treatment will be determined by institutional policy. The researchers will also be looking at whether this study could significantly improve the future management and quality of life of rectal cancer patients.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-09-26; most recent amendment 2025-06-16.
Trial Details
NCT Number NCT06057831
Lead Sponsor AHS Cancer Control Alberta
Conditions Rectal Cancer
Enrollment 40 participants
Start Date 2026-05
Primary Completion 2029-05 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2025-06-18